Cargando…

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma

BACKGROUND: This study clarified whether EMT-related genes can predict immunotherapy efficacy and overall survival in patients with HCC. METHODS: The RNA-sequencing profiles and patient information of 370 samples were derived from the Cancer Genome Atlas (TCGA) dataset, and EMT-related genes were ob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yanlong, Wang, Jingyan, Huang, Guo, Zhu, Jun, Jian, Haokun, Xia, Guozhi, Wei, Qian, Li, Yuanhai, Yu, Hongzhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349121/ https://www.ncbi.nlm.nih.gov/pubmed/35699863 http://dx.doi.org/10.1007/s12072-022-10354-3

Ejemplares similares

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2022)

Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
por: Wu, Guozhi, et al.
Publicado: (2021)

Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis
por: Zhou, De-Hua, et al.
Publicado: (2022)

Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
por: Shao, Xuyang, et al.
Publicado: (2022)

The global status of research in breast cancer liver metastasis: a bibliometric and visualized analysis
por: Shi, Yanlong, et al.
Publicado: (2021)

A novel epithelial–mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer
por: Jin, Yichao, et al.
Publicado: (2023)

NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial–mesenchymal transition by activating the Wnt/β-catenin signaling pathway
por: Shi, Yanlong, et al.
Publicado: (2022)

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021)

Identification of a Novel Epithelial–Mesenchymal Transition-Related Gene Signature for Endometrial Carcinoma Prognosis
por: Ruan, Tianyuan, et al.
Publicado: (2022)

Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients
por: Huang, Shenglan, et al.
Publicado: (2022)

The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer
por: Liang, Jiayu, et al.
Publicado: (2018)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
por: He, Lu, et al.
Publicado: (2014)

Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Zhou, Yongjie, et al.
Publicado: (2022)

Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma
por: Yu, Hongmin, et al.
Publicado: (2023)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma
por: Ai, Jun, et al.
Publicado: (2023)

Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
por: Xu, Bang-Hao, et al.
Publicado: (2021)

Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis
por: Xu, Huiyong, et al.
Publicado: (2021)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
por: Song, Junquan, et al.
Publicado: (2022)

RETRACTED ARTICLE: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma
por: Lei, Xiong, et al.
Publicado: (2017)

Retraction Note: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma
por: Lei, Xiong, et al.
Publicado: (2018)

Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules
por: Xu, Lijun, et al.
Publicado: (2021)

The transcriptome signature analysis of the epithelial-mesenchymal transition and immune cell infiltration in colon adenocarcinoma
por: Heryanto, Yusri Dwi, et al.
Publicado: (2023)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma
por: Feng, Shengyu, et al.
Publicado: (2022)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
por: Qu, Shuang, et al.
Publicado: (2023)

An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
por: Lin, Zhuo, et al.
Publicado: (2021)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review
por: Gurzu, Simona, et al.
Publicado: (2019)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Promising Prognosis Marker Candidates on the Status of Epithelial–Mesenchymal Transition and Glioma Stem Cells in Glioblastoma
por: Takashima, Yasuo, et al.
Publicado: (2019)

NF-κB–Dependent Snail Expression Promotes Epithelial–Mesenchymal Transition in Mastitis
por: Liu, Haokun, et al.
Publicado: (2021)

Assessment of epithelial–mesenchymal transition signatures in oral submucous fibrosis
por: Prasad, R Shesha, et al.
Publicado: (2019)

An Integrating Immune-Related Signature to Improve Prognosis of Hepatocellular Carcinoma
por: Zhu, Rui, et al.
Publicado: (2020)

Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma
por: Jung, Ah Ra, et al.
Publicado: (2020)

An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer
por: Tong, Hang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kva8292jt6vqsre3kjbil8sd5f